secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alkermes plc. (ALKS)
CIK:        0001520262
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002678
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alkermes to present at J.P. Morgan Healthcare Conference; highlights profitability and neuroscience focus
--------------------------------------------------------------------------------

- Presentation on Jan 10, 2024, titled 'Profitable, Pure-play Neuroscience Company'.
- CEO Richard Pops to present at the 42nd Annual J.P. Morgan Healthcare Conference.
- No specific financial or operational data disclosed in the excerpt provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/0000950170-24-002678-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/alks-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002678

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer